Revlixen (Lenalidomide) 10 mg & 25 mg

What is Revlixen (Lenalidomide)?

Revlixen (Lenalidomide) is a prescription medication used to treat multiple myeloma in combination with dexamethasone or as maintenance treatment after Stem cell transplant using the patient’s own cells. It should not be used to treat patients with chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if Revlixen is safe and effective in children.

“On February 22, 2017, the U.S. Food and Drug Administration approved lenalidomide (Revlimid, Celgene Corp.) as maintenance therapy for patients with multiple myeloma following autologous stem cell transplant.” Mentioned on the FDA approval page.

What is the most important information I should know about Revlixen (Revilimid)?

Before you take the Revlixen, your healthcare provider will explain all the instructions and information to you. You have to know the following things before you start with Revlixen.

Revlixen may cause possible birth defects (deformed baby) or death of an unborn baby. 

Females who are pregnant must not take Revlixen. It has not been tested in pregnant women, but after testing in pregnant animals, it harmed unborn animals.

Females must not be pregnant

• At least 4 weeks before taking Revlixen
• During treatment with Revlixen
• At the interval of the treatment
• And at least 4 weeks after the last dose of Revlixen.

Females who can become pregnant

• They must have pregnancy tests weekly for the first 4 weeks, then once in every 4 weeks if the menstrual cycle is regular, and once in every 2 weeks if the menstrual cycle is irregular. 
• If you miss your period and have unusual bleeding, you need pregnancy tests and counseling.
• Female patients must agree to take 2 different forms of birth control before 4 weeks of taking Revlixen, while taking the medication, during any break in the treatment, and until 4 weeks after the last dose.
• Talk with your healthcare provider about effective birth control that may prevent pregnancy before, during, during the break, and after the treatment. 
• If you think you had unprotected sex or that birth control has failed, talk to your healthcare provider immediately. 

Who should not take Revlixen (Lenalidomide)?

Do not take Revlixen (Lenalidomide) if you are 

• Pregnant, or planning to get pregnant during the treatment, before starting treatment, during the break from treatment, and at least 4 weeks after the treatment. 
• Allergic to Lenalidomide or any of the ingredients in Lenalidomide.

What should I tell my healthcare provider before taking Revlixen (Lenalidomide)?

Before you take Revlixen, tell your doctor about all the medical conditions you have, all the medications you are taking, and also include the following

• Liver problems
• Kidney problem, or if you had kidney dialysis treatment
• Thyroid problems
• Had a severe skin rash with thalidomide treatment. You should not take the medication.
• If you are lactose intolerant, Revlixen contains lactose
• If you are breastfeeding, do not breastfeed during the treatment. It is not known if the Revlixen passes through the breast milk.

Tell your healthcare provider about all the medicines you take. You should inform your doctor about all the prescription, non-prescription ,and herbal supplements you take before starting with Revlixen. It reacts with other medicines and may cause problems with absorption in the body.

How should I take Revlixen (Lenalidomide)?

Take the medication exactly as prescribed in the prescription and follow all the instructions provided by revlimid.com (parent website of Revlimid).

• Swallow the whole capsule with 1 glass of water; do not open the capsule or chew it. 
• It can be taken with or without food.
• Take the medication at the same time every day.
• Do not open or break the capsule. If the powder of the capsule comes in contact with your hand, wash your hand with soap. If it comes into contact with your eyes, flush your eyes well with normal water until it is washed out.
• If you miss a dose and it is less than 12 hours, take the missed dose as soon as possible. Do not take the missed dose if it is more than 12 hours.

What are the possible side effects?

Revlixen (Lenalidomide) can cause serious side effects, including 

• You should not take the medication if you have chronic lymphocytic leukemia. It increases the risk of heart attack, heart failure in CLL patients.
• It increases the risk of new cancers in patients who received melphalan, or a blood stem cell transplant, including certain blood cancers, such as acute myelogenous leukemia (AML), myelodysplastic syndromes (MDS), and certain other types of cancers of the skin and other organs. Talk with your healthcare provider about the risk of developing a new cancer. Your healthcare provider will monitor your health during the treatment and the possibility of growing new cancer.
• Severe liver problems and liver failure. Tell your healthcare provider if you see any of these symptoms: yellowing of the skin or white part of the eyes, pain on the upper right side of your stomach, dark or brown urine, bleeding or bruising more easily than normal, or feeling very tired.
•  Severe skin reactions and severe allergic reactions, such as a red or itchy skin rash, peeling of your skin, and severe itching. 

Get emergency medical help right away if you develop any of the following signs or symptoms during the treatment.

• Swelling of your lips, mouth, tongue, or throat.
• Raised red areas of your skin
• Trouble breathing or swallowing
• A very fast heartbeat 
• If you feel dizzy or faint

Price and Manufacturer information of Revlixen

Revlixen (lenalidomide) is a prescription oncology medicine supplied for use under specialist clinical supervision. For visitors searching for lenalidomide 25 mg price in Bangladesh, please note that pricing varies by region, batch, and time — current pricing and local availability are provided on request through authorized channels. Everest Pharmaceutical, a Bangladesh-based manufacturer, reports WHO and GMP certifications for its production facilities. Global access to Revlixen is coordinated via licensed distributors and intermediaries such as Onus Pharma, who handle availability and pricing enquiries between manufacturers, licensed pharmacies, and healthcare professionals; a valid prescription and compliance with local regulations are required.